RXST
Rxsight IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$305.51M
P/E Ratio
—
EPS
$-0.95
Beta
1.24
52W High
$16.74
52W Low
$5.90
50-Day MA
$7.23
200-Day MA
$8.78
Dividend Yield
—
Profit Margin
-29.00%
Forward P/E
238.10
PEG Ratio
—
About Rxsight Inc
Rxsight Inc. is an innovative healthcare technology company focused on revolutionizing vision correction through cutting-edge diagnostic and surgical techniques in refractive eye surgery. By leveraging proprietary software and precision-guided laser technology, Rxsight enhances patient outcomes and elevates the quality of life for individuals seeking vision correction. The company boasts a strong intellectual property portfolio and strategic partnerships, reinforcing its competitive edge in the rapidly growing ophthalmic market. With a steadfast commitment to innovation and excellence, Rxsight is well-positioned for substantial growth and transformative impact in the evolving landscape of eye care.
Fundamentals
| Revenue (TTM) | $134.48M |
| Gross Profit (TTM) | $103.01M |
| EBITDA | $-44.92M |
| Operating Margin | -34.80% |
| Return on Equity | -14.00% |
| Return on Assets | -9.56% |
| Revenue/Share (TTM) | $3.29 |
| Book Value | $6.68 |
| Price-to-Book | 1.11 |
| Price-to-Sales (TTM) | 2.27 |
| EV/Revenue | 0.662 |
| EV/EBITDA | -7.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -18.90% |
| Shares Outstanding | $41.40M |
| Float | $36.92M |
| % Insiders | 5.66% |
| % Institutions | 88.46% |
Historical Volatility
HV 10-Day
56.49%
HV 20-Day
60.37%
HV 30-Day
57.91%
HV 60-Day
60.11%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($9.93 target)
1
Strong Buy6
Hold2
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026